Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch)

Table 2 Cardiac medications initiated since primary study completion

	Overall (N = 52)	Placebo (N = 15)	Perindopril (N = 16)	Bisoprolol (N = 21)	p-value
Beta blocker	2 (4%)	0 (0%)	1 (6%)	1 (5%)	0.999
ACEi /ARB	4 (8%)	1 (7%)	2 (13%)	1 (5%)	0.81
Diuretic	2 (4%)	0 (0%)	0 (0%)	2 (10%)	0.33
Diabetes treatment	1 (2%)	0 (0%)	0 (0%)	1 (5%)	0.999
Statin	4 (8%)	0 (0%)	2 (13%)	2 (10%)	0.54
Calcium channel blocker	0 (0%)	0 (0%)	0 (0%)	0 (0%)

Values are number (column %)
ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker

ISSN: 2057-3804